132 related articles for article (PubMed ID: 36029956)
1. A pre-operative radiological score to predict lymph node metastasis in advanced epithelial ovarian cancer.
Crestani A; Huchon C; Mezzadri M; Marchand E; Place V; Cornelis F; Touboul C; Haddad B; Dabi Y; Benifla JL; Mimoun C
J Gynecol Obstet Hum Reprod; 2022 Nov; 51(9):102464. PubMed ID: 36029956
[TBL] [Abstract][Full Text] [Related]
2. Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group.
Mimoun C; Paoletti X; Gaillard T; Crestani A; Benifla JL; Mezzadri M; Bendifallah S; Touboul C; Bricou A; Dabi Y; Canlorbe G; Kerbage Y; Lavoué V; Ouldamer L; Lecointre L; Coutant C; Fauconnier A; Rouzier R; Huchon C
PLoS One; 2021; 16(10):e0258783. PubMed ID: 34665839
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer.
Xue B; Wang X
Sci Rep; 2023 Jun; 13(1):9439. PubMed ID: 37296189
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
5. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
[TBL] [Abstract][Full Text] [Related]
7. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
8. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer.
Harter P; Gnauert K; Hils R; Lehmann TG; Fisseler-Eckhoff A; Traut A; du Bois A
Int J Gynecol Cancer; 2007; 17(6):1238-44. PubMed ID: 17433064
[TBL] [Abstract][Full Text] [Related]
9. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Hynninen J; Auranen A; Carpén O; Dean K; Seppänen M; Kemppainen J; Lavonius M; Lisinen I; Virtanen J; Grénman S
Gynecol Oncol; 2012 Jul; 126(1):64-8. PubMed ID: 22542580
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
12. [Are there still indications of lymph node dissection in epithelial ovarian cancers after the LION trial?].
Azaïs H; Canlorbe G; Nikpayam M; Gonthier C; Belghiti J; Uzan C
Bull Cancer; 2020 Jun; 107(6):707-714. PubMed ID: 31587803
[TBL] [Abstract][Full Text] [Related]
13. A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer.
Xiang H; Yang F; Zheng X; Pan B; Ju M; Xu S; Zheng M
Curr Oncol; 2023 Mar; 30(3):3289-3300. PubMed ID: 36975463
[TBL] [Abstract][Full Text] [Related]
14. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of lymph node metastasis and pattern of repartition in patients with epithelial ovarian cancer.
Atallah D; Arab W; Dagher B; Khalil N; El Rawadi E; Atallah B; Ghaname W; El Kassis N; Chahine G; Moubarak M
Future Oncol; 2021 Dec; 17(36):5093-5101. PubMed ID: 34821515
[No Abstract] [Full Text] [Related]
16. Eradication of Isolated Para-Aortic Nodal Recurrence in a Patient with an Advanced High Grade Serous Ovarian Carcinoma: Our Experience and Review of Literature.
Tinelli R; Dellino M; Nappi L; Sorrentino F; D'Alterio MN; Angioni S; Bogani G; Pisconti S; Silvestris E
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208568
[TBL] [Abstract][Full Text] [Related]
17. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis.
Larish A; Mert I; McGree M; Weaver A; Sheedy S; Cilby W
Int J Gynecol Cancer; 2020 Apr; 30(4):504-508. PubMed ID: 31953350
[TBL] [Abstract][Full Text] [Related]
18. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
Berek JS
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
[TBL] [Abstract][Full Text] [Related]
19. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
20. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
